Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease (SERENADE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03153111
Recruitment Status : Completed
First Posted : May 15, 2017
Last Update Posted : March 24, 2021
Sponsor:
Information provided by (Responsible Party):
Actelion

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 12, 2021
Actual Study Completion Date : March 12, 2021